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ABSTRACT
GO FOR A WALK! MONITORING WALKING FOR DEPRESSED MOOD
By
Michael Edwin Shrake
Literature suggests that exercise has benefits for health and mood. For people
suffering from depression however, even summoning motivation to go for a walk can
seem impossible, no matter the alleged benefits. My study builds on current articles
suggesting that wearable technology like activity-tracking bracelets can have significant
effects on motivation and physical health goals.

The current study followed 11

individuals who met the minimum threshold for depression as measured by the Patient
Health Questionnaire-9 (PHQ-9) for a period of 28 days and tracked their walking using a
Jawbone UP activity bracelet.

The results showed that daily activity differed

significantly across participants and did not have an effect on daily scores on PHQ-9
questions except for the Question 5 related to appetite. These scores increased
significantly at the end of the period (day 27 specifically) but also decrease significantly
the following day (day 28) suggesting that appetite concerns fluctuate day to day and do
not necessarily correlate with the number of steps. Concerns about sleep were less
intense on average during the first week but fluctuated across the remaining three weeks.
Scores indicating whether participants felt bad about themselves varied between high and
low scores over the period and had no correlation with the number of steps.
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INTRODUCTION

This study is concerned with how monitoring physical activity affects mood on a
day-to-day basis. Literature on depression suggests that exercise may reduce symptom
severity for depression (Aurelio et al. 2005, Dixon et al. 2003, Luppino et al. 2010,
Lepine & Briley 2011) and that activity trackers can improve motivation. First, the daily
relationship between specific depression symptoms and physical activity such as walking
is non-existent. Second, to my knowledge no study has tried to monitor daily walking
activity with same-day specific symptom severity for depressed people. My thesis
explores, to some extent, the relationship between daily walking and depression
symptoms using the Patient Health Questionnaire for depression, also known as the PHQ9 and an activity tracker bracelet (UP™ by Jawbone).
In this work, daily walking was defined as the number of steps the participant
takes per day and was recorded using the bracelet for a duration of 28 days; while over
the same period the participants were asked to complete a modified PHQ-9 on a daily
basis.
The original PHQ-9 was designed to be taken every two-weeks but it can also be
adapted for shorter periods such as in a study by Torous et al (2015), where participants’
1

daily mood was collected every day through texting. Another study showed that daily
ratings can be used to illustrate a more detailed picture of the depression profile of an
individual compared to the traditional instructions of the PHQ-9, where the daily high
and low intensity of symptoms are averaged into a single score across the previous two
weeks (Aguilera et al, 2015). Aguilera et al (2015) suggested that asking an individual to
recall symptom frequency over the previous two weeks may be subject to a recency bias.
In our case, we slightly modify the questionnaire by asking the participants to report their
symptoms on a daily basis rather than over a two week period.
Chapter 1 is an overview of modern depression and the effect of walking on
depression. This chapter starts with a discussion of differences in the defining features of
depression between the earliest diagnostic manuals and the most current.

It also

discusses the development and the use of depression screening inventories along with
differences in the frequency of diagnosis between genders.

The following section

focuses on walking as a treatment for mild depression. It begins with a discussion of
common depression interventions such as cognitive behavioral therapy and psychiatric
medication. Walking is proposed as an intervention for mild depression, which does not
require the higher level of care provided by a therapist or psychiatrist.

Literature

examining the effect of exercise on mood is discussed, followed by a handful of studies
that utilized pedometers and health surveys to track changes in physical and emotional
wellness, as well as the tracking devices’ effect on motivation.
Chapter 2 goes over the study itself and our results. We selected a depression
screening inventory (the PHQ-9) and utilized it to screen potential participants for a
minimum threshold of depression.

Participants in our sample received an activity
2

tracking bracelet and then completed a PHQ-9 modified for daily use for 28 days. Data
were analyzed using a Linear Mixed Model in SPSS. We found that the number of days
wearing the tracker bracelet had a significant effect on the variance of PHQ-9 questions
across participants but no significant effect on the scores of PHQ-9 over time except for
question 5 which is related to eating too much or too little. Finally, while our study did
not find an effect for Day of participation on the number of steps, correlating the number
of daily steps to the day’s PHQ-9 sum score produced a negative correlation for eight of
eleven participants.
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CHAPTER ONE: MODERN DEPRESSION
1. DEPRESSION
Depression is a common mood disorder found worldwide across age, gender, and
demographic (Robertson et al, 2012).

It effects professional, social, and emotional

interaction including work productivity, intimate relationships, and daily moods.
Symptoms typically include sadness, apathy, and a feeling of emotional isolation or
detachment (Bostwick & Pankratz, 2000). Though an average depressive episode lasts
between three and six months, depression can be recurrent and a lifetime struggle (Lepine
& Briley 2011).
Diagnostic criteria for depression have evolved over time and are regularly revised
with new editions of diagnostic manuals such as the Diagnostic and Statistical Manual of
Mental Disorders (DSM) and the International Statistical Classification of Diseases and
Related Health Problems (ICD). With progressive editions of the DSM, the lifetime
prevalence of depression had increased from 3% of the population in 1970 (with the
DSM-II) to 10-20% in 1994 (with the DSM-IV) (Bostwick & Pankratz, 2000). It is
important to note that different definitions of depression, particularly between editions of
diagnostic manuals, which emphasized or omitted different symptoms, contributed to the
ballooned rates of prevalence. The DSM-II defined “Manic-depressive illness, depressed
type” as a disorder characterized by severely depressed mood and mental and motor
retardation (American Psychiatric Association, 1975).

Additional symptoms could

include uneasiness, apprehension, perplexity, and agitation. Manic-depressive illness,
depressed type differed from manic or circular types in that it consisted exclusively of
4

depressed episodes (American Psychiatric Association, 1975). By contrast, the DSM-IVTR features seven mood disorder diagnoses where depression can be the primary
symptom, including two diagnoses that classify the depression diagnosis either as an
episode or a disorder (major depressive episode/disorder and bipolar episode/disorder)
(American Psychiatric Association, 2000). The DSM 5 elaborates further, distinguishing
eight distinct diagnoses in the section “Depressive Disorders”, spanning 33 pages; a
significant elaboration from the page and a half of the DSM-II (American Psychiatric
Association, 1975, 2013)!
The DSM 5 includes:

Disruptive Mood Disregulation Disorder; Major

Depressive Disorder; Persistent Depressive Disorder (Dysthymia); Premenstrual
Dysphoric Disorder; Substance/Medication-Induced Depressive Disorder; Depressive
Disorder Due to Another Medical Condition; Other Specified Depressive Disorder; and
Unspecified Depressive Disorder. Each of these diagnoses is characterized by a sad,
empty or irritable mood along with significant somatic and cognitive changes, which
impair the individual’s capacity to function.

They differ in duration, timing, and

presumed etiology (See Appendix B for more detailed definition of each disorder).

1.1.

ASSESSING DEPRESSION

To assess depression several tests and scales have been developed following DSM
criteria. These include the Beck Depression Inventory – II (BDI-II) (Beck, Steer, &
Brown, 1996) and the PHQ-9 (Kroenke et al., 2001). The BDI-II is a revision of the
widely used Beck Depression Inventory (BDI), introduced in 1961 as a 21-question
survey designed to measure the behavioral manifestations of depression (Beck et al,
1996, Beck et al, 1961). A new edition of the BDI-II was released 35 years later in 1996
5

in response to incremental changes in symptoms defining depression, including revisions
in the DSM. It is used to identify specific depression symptoms and their frequency for
psychiatrically diagnosed adults and adolescents, but it is not used as a lone diagnostic
tool, as symptoms of depression may be part of a separate primary disorder (Beck et al,
1996). The Patient Health Questionnaire (PHQ-9) is a nine-item survey used to screen
for depression and symptom severity (Lowe et al. 2003). It was developed by Pfizer in
the early 1990’s as part of PRIME-MD, an instrument used to assist clinicians in making
criteria-based diagnosis of five DSM-IV disorders commonly encountered in medical
patients (Kroenke & Spitzer, 2002). Kroenke et al. (2001) found it was well-validated in
fifteen studies including over 6,000 patients. Because it is entirely self-administered and
brief, the PHQ-9 is now the most commonly used depression screening tool in clinical
and research settings (Malpas et al. 2010; Lowe et al. 2003; Kroenke & Spitzer 2002).
The PHQ-9 assesses an individual’s depression symptoms over two weeks, since
according to the DSM-IV, “a symptom must be present for at least two weeks to be
included in a diagnosis of depression.” For research purposes, to evaluate the effect of a
specific factor such as walking in our case, it is possible to modify the PHQ-9 for daily
ratings as they reflect the mood more closely (Aguilera et al., 2015). Korenke et al.
(2001) report that PHQ-9 scores of 5, 10, 15, and 20 represent the lowest thresholds for
mild, moderate, moderately severe, and severe depression respectively.

1.2.

GENDER DIFFERENCE

Women are approximately 1.7 times more likely than men to report a lifetime
history of depression but do not differ in the overall course of depression nor the
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likelihood of a recurrence in the subsequent twelve months (Kessler et al., 1993, NolenHoeksema, 1991).
There is also no significant difference in the average age of the depression onset
between men and women (24.04 years old and 23.53 years old respectively) (Kessler et
al, 1993). Nolen-Hoeksema (1987) found that, with few exceptions, women report more
depressive symptoms than men worldwide. The researcher evaluated possible differences
in relations between several psychosocial, economic, and biological factors between the
two genders but none of them was significant. The researcher suggested that this
difference could be related to their responses to stress and engagement in distractive
behaviors, as females tend to report ruminative behaviors with lower levels of general
activity, while males generally pursue distractions from stress including physical activity
(Nolen-Hoeksema, 1987). The physical activity engagement and relationship to mood is
explored in depth in the following section.
In a different study, Nolen-Hoeksema & Girgus (1994) suggested that ruminativestyle responses were related to higher depression scores for both genders. One proposed
explanation by Nolen-Hoeksema (2003) is that rumination on negative emotions, even
with the intention of problem solving, can draw the individual into negative cycles of
thinking which in turn reduces the quality of proposed solutions. Whether rumination is
a self-reflective style focused on solutions or a brooding style focused on negativity is
specifically related to variations in levels of depression for women, where rumination
with brooding traits correlated with elevated levels of depression. Though females were
significantly more likely to demonstrate ruminative responses than males, both genders
exhibited higher rates of depression with ruminative responses in general than other types
7

of response and it is suggested that response style may be more indicative of
susceptibility to depression than gender alone (Nolen-Hoeksema & Girgus 1994, NolenHoeksema 2003). However, gender may influence which response styles an individual
develops.
Differences in typical response style is proposed to be a product of social
reinforcement: men are praised or belittled for emotional responses based on social
concepts of masculinity (“act like a man”); while emotional responses in girls receive less
attention, whether positive or negative, compared to boys; which could lead to learned
helplessness and a greater likelihood of depression (Nolen-Hoeksema, 1991). Children
of either gender may develop a ruminative or passive response to negative affect if their
parents/caregivers model a ruminative response style at home. This response style may
also develop if the child is not exposed to appropriate adaptive responses, which may
include benign distraction or appropriate problem solving (Nolen-Hoeksema, 1991). It
has been suggested that depressed people with ruminative response styles may recover
after learning to control the ruminative response through distraction during the course of
CBT (Nolen-Hoeksema, 1991).

2. WALKING AS A TREATMENT FOR DEPRESSION
As mentioned previously, engaging in physical activity is considered a distractive
behavior and therefore could be related to less depressive mood (Nolen-Hoeksema, 1987,
Nolen-Hoeksema, 1991). Modern treatment of depression typically includes cognitive
behavioral therapy (CBT) and/or prescription medication. Vernmark et al (2010) report
that several psychological interventions have shown relatively similar outcome effects for
depression from CBT, online CBT, and prescription medication. Cognitive behavioral
8

therapy consists of identifying and modifying faulty thought processes, attitudes, and
behaviors, and is often paired with psychopharmacological treatments (Durand 2010,
Butler et al., 2006). Robertson et al. (2012) stated that treatment with antidepressants is
not recommended for people with mild depression and suggested that physical activity
should be evaluated for therapeutic use with depressed patients because it might alleviate
depression.
Other studies have demonstrated that there is a relationship between activity level
and mood (Aurelio et al. 2005, Dixon et al. 2003, Luppino et al. 2010, Lepine & Briley
2011). Some researchers have found evidence to support the activity of walking as a
treatment for depression, though their experiment did not examine which specific
symptoms were effected, reporting only whether symptoms in general improved, stayed
the same, or got worse over the course of the study (Mobily et al. 1996). Though this
study focused on elderly rural adults, it found that even light-intensity exercise such as
walking had a positive correlation with the reduction of depressive symptoms. Changes
in exercise behavior were predictive of depressive symptoms at a follow-up three years
later, while overall the data suggest that this daily level of exercise can reduce depressive
symptoms at mild, moderate, and severe levels of depression.

Another researcher

proposed that physical activity functions as a distraction to negative moods, particularly
in depression, by diverting attention to a task and preventing rumination (NolenHoeksema, 1987).
An additional benefit of light exercise (such as walking) while treating depression
is that it is a viable option for most people, even those who may be geographically or
financially unable to spend time with a therapist. As reduced energy and activity is a
9

common symptom of depression and could rationally impede light daily exercise, we
sought a motivational component to possibly enhance the number of steps a person might
take in a day (Salmon, 2001).

3. FITNESS TRACKERS AND THEIR EFFECT ON MOTIVATION
There have been a handful of recent studies examining the effectiveness of fitness
trackers on motivating less-active people to become more active. The use of pedometers
has helped adults and seniors to improve health by significantly lowering blood pressure,
body mass index (BMI), and achieve daily step targets (Klein, 2015).

Wearable

technology such as activity bracelets are becoming more advanced by the year and their
accuracy in monitoring numbers of steps taken, duration and quality of sleep, and other
biometrics ought to be regularly applied to new research in a variety of intersectional
studies (Paul et al., 2015, Attick, J. et al., 2016).

Beyond personal use, wearable

technology could help physicians monitor patients remotely between visits, which itself
could be helpful for rural or elderly populations (Attick, J. et al. 2016).
A community study in Scotland found that participants who were given a pedometer
for twelve weeks and completed daily reports on step counts and health outcomes
significantly increased their step count (p < .001), time spent in leisure walking, and
positive mood compared to a control group (Baker et al. 2008).

The researchers

cautioned that the health consultation about the benefits of walking in their study has
previously been shown to increase daily activity by itself, though no significant effect for
the consultation alone increased daily walking in their study. A meta-analysis found a
significant effect for motivation on the number of steps with pedometers when
participants recorded their activity by hand on a monthly calendar (Tudor-Locke and
10

Lutes, 2009). Participants who manually recorded their numbers each day reported a
mean daily step increase of 2000 steps per day over baseline, while those who wore the
pedometer without recording their steps increased daily step count by a mean of 832
steps. Participants in the study explained that a tangible record of their steps worked as a
motivator, particularly when comparing their current day steps to previous days. Since
activity trackers help with the motivational levels of the person wearing it, we wondered
whether their usage could enhance the motivational levels of people suffering from mild
depression to engage more often in walking. Measurements for motivation were inferred
by an increase in daily number of steps across the month of participation.

4. CONCLUSION
The evaluation of symptom severity and its modulation with various daily walking totals
creates a number of opportunities for research and therapeutic applications. Walking is
generally a safe, healthy, achievable goal for patients exhibiting a range of psychological
maladies including depression. The use of activity tracking devices including pedometers
and bracelets has been shown to motivate a variety of populations to increase their daily
step rate, resulting in numerous health benefits and often an increase in positive affect.
The examination of the relationship between specific depression symptoms and the
number of daily steps should provide groundwork for future investigations into the
modulatory effects of daily activity upon symptoms of depression.
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CHAPTER TWO: WALKING
TREATMENT FOR DEPRESSION

AS

A

POTENTIAL

1. INTRODUCTION
The purpose of this study is to explore the relationship between walking and depression
scores for individuals who reported mild depression, and to investigate whether fitness
trackers that monitor activity such as walking can motivate these individuals to keep up
with their activity, demonstrated by an increase in the number of daily steps from the
beginning of the study to the end. Previous studies have examined the relationship
between mood and various forms of exercise, but to our knowledge, no one correlated the
total number of steps by day with daily depression scores for an extended period of time
(twenty-eight days). On one hand, we used walking specifically because 1) it does not
require any cost, 2) it can be easily tracked (using a fitness bracelet), and 3) it was
suggested as an intervention for mild to moderate depression in a study by Robertson et
al. (2012). On the other hand, with the emergence of activity trackers on the market that
have been shown to enhance motivation, we would like to assess their motivational role
when a person’s mood is down.

2. METHODS
2.1.

PARTICIPANTS

Participants were recruited from undergraduate Northern Michigan University courses in
general psychology, statistics, and research methods. Recruitment of students took place
via email from professors to their respective class lists. Students were informed in the
email that there was a brief survey about emotion and that a larger study would be taking
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place utilizing an activity tracking bracelet and brief nightly surveys. Eleven students,
nine females, participated in the full study after prescreening. Participants ranged in age
between 18 and 42 years (mean: 23.08 years, standard deviation: 6.63 years). The mean
baseline PHQ-9 score for selected participants was 13.58, with a standard deviation of
5.53 and a range from 6 points to 25 points.

2.2.

STIMULI AND APPARATUS

Participants were provided with a “Jawbone UP”™ health tracking bracelet for use
through the duration of the study. A study evaluating the accuracy of ten different
activity trackers found this bracelet to be reliable when monitoring walking in laboratory
and home settings with the mean absolute percentage error (-1.0, 1.4) respectively
(Kooiman et al., 2015). Data from the bracelets were collected weekly using iPads with
the Jawbone app. Data were processed using Excel and SPSS. Participants were
instructed to remove the bracelet only to charge once weekly at night and when bathing
or swimming as it is not waterproof.

Participants received an email at 9:00 PM each

evening with the modified PHQ-9 Survey. They were instructed to complete the survey at
the end of each day.

13

2.3.

PROCEDURE

2.3.1. PRE-SCREENING:
Volunteers were directed to a website (Qualtrics, Provo, UT) to complete a modified
PHQ-9 survey (Appendix 1). Three hundred and eighty eight volunteers completed the
pre-screening survey across the course of the study, with the pre-screening offered at the
beginning of each academic semester beginning with summer 2016. Of one hundred and
ninety participants who scored at least 5 points (the minimum threshold for mild
depression) and higher, eighty indicated an interest in participating in the full study and
were emailed an invitation to participate. Participants were selected on a first-response
basis. The incentive for completing the screening survey was extra credit in class. The
incentive for completing the full 28 day study was a $20 gift card to Target.
A final participation sample of eleven subjects were selected from all invited
participants. Screened individuals were instructed on the procedures of the study and
provided their consent to participate in the study. Bracelets were to be worn around the
clock except when charging or in the shower, and were worn on the participants’ arm of
choice. Data was not collected concerning the arm of preference for the participant. The
study was approved after review by the Institutional Review Board (IRB) of Northern
Michigan University in February 2016 (approval code HS 16-761).
2.3.2. EXPERIMENT
Data recorded on the Jawbone bracelet began with the first full day the participant
wore the bracelet. Surveys were sent at 9:00 PM each evening to participants’ preferred
email address beginning on the first full day of data collection. Participants met with the
researcher once a week to collect data from the wristbands in most cases. If such a
14

meeting was missed, data were usually collected within a couple of days. When the
participant had completed 28 surveys with activity data for each day, participation was
considered fulfilled, the bracelet was returned, and the participant received the promised
$20 gift card. Participants with five or more days of missing survey data did not receive
the incentive.
The nightly survey for participants featured a PHQ-9 which was altered to inquire
only about the previous 24 hours.

The survey also included four social questions

inquiring as to what extent the participant interacted with close friends, interacted with
family, spent time on leisure activities, and time spent idly during the day. In this study
the daily number of steps is a predictor variable while specific symptom severity is a
criterion variable. When evaluating motivation successive days is a predictor variable
while the number of steps is the criterion variable.

2.4.

ANALYSIS

Data were analyzed in SPSS using a Linear Mixed Model (LMM) with Days as a
factor. The LMM provides a better fit of the data over a repeated measured analysis for
the same dataset since our data are considered longitudinal repeated measures. It can also
handle missing point times in case participants forgot to fill in the PHQ-9 questions.
Repeated measures LMMs were used as each participant’s questions were recorded 28
times, with Participant (11) entered as a random effect (intercept), and Days (28) entered
as a fixed effect. For each step, the significance of the fixed effect Days was assessed
with Type III SS F-tests on the final multivariate model. Changes in model fit for fixed
effects were assessed with maximum likelihood (ML) estimation. For all the questions,
models were fitted using AR(1) (first-order autoregressive) and ARH(1) (heterogeneous
15

first-order autoregressive) that are more suited to longitudinal repeated measures (Field,
2013).

3. RESULTS:
This study was designed to examine the relationship between monitoring physical
activity and depression symptom severity for people experiencing mild depression. The
eleven participants (nine female) raged in age from 18-42, with a mean age of 23.
Baseline scores on the PHQ-9 from our participants ranged from 6-25 points, with a
mean score of about 13.5. Across 308 individual surveys for the 11 participants, 30 were
not completed.
Motivation was monitored by the number of steps taken per day from Day 1 to Day
28. Daily symptom severity was measured using the PHQ-9 and each symptom was
analyzed across participants by Day.

A daily depression severity sum score was

correlated for each participant with the number of steps they took that same day.

3.1.

RESULTS: STEPS

Figure 1 shows the number of steps against days for each participant. Six of the
eleven participants (P1, P5, P6, P7, P10, P11) showed a broad range of activity best
depicted with a moving average. Two participants (P2, P3) started their participation at
or near their highest levels of recorded steps before quickly dropping away to reporting
no steps at all. P9 is similar to P2 and P3, but with more variance in the number of steps
between days before ceasing to report number of steps.
Participants P4 and P8 demonstrated general upward trends in number of steps
taken by day. P4 shows a logarithmic trend line, their rate of increase in steps per day
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gradually slowing across days. Participant P8 follows a gradual linear positive slope,
increasing steps per day particularly in the final week of their participation. Using the
LMM, the relationship between days and steps showed significant variance in intercept
across participants Var(u0j) = 4.98 x 1013, 2(1) = 15.96, p < .01. Each participant
recorded significantly different numbers of steps at the beginning of the study, and their
pattern of steps across days differed between each participant. No two participants were
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FIGURE 1. THE NUMBER OF STEPS PER DAY BY PARTICIPANT.

3.2.

RESULTS: PHQ-9

3.2.1. PHQ-9: QUESTION1:
Question 1 from the PHQ-9 deals with diminished interest or pleasure in doing
things. It asked the participants: “Over the last 24 hours, have you experienced little
interest or pleasure in doing things?” The relationship between days and PHQ-9-1
showed significant variance in intercept across participants, Var(u0j) = .15, 2(1) = 24.5, p
< .01. However, days did not significantly affect question 1 of the PHQ-9.
3.2.2. PHQ-9: QUESTION2:
Question 2 from the daily PHQ-9 asked participants: “Over the last 24 hours, have
you experienced feeling down, depressed, or hopeless?” The relationship between days
and PHQ-9-2 showed significant variance in intercept across participants, Var(u0j) = .016,
2(1) = 32.79, p < .01. Question 2 of the PHQ-9 was not significantly affected by Days.
3.2.3. PHQ-9: QUESTION3:
Question 3 from the PHQ-9 enquires about sleep concerns. Participants were asked:
“Over the last 24 hours, have you experienced trouble falling or staying asleep, or
sleeping too much?” The relationship between days and PHQ9-3 showed significant
variance in intercept across participants, Var(u0j) = .026, 2(1) = 46.62, p < .01. Days h
significantly affected question 3 scores of the PHQ-9 (p = 0.08). Figure 2 shows the mean
scores per day for question 3. It seems that participants’ sleep was improving during the
first 10 days but start fluctuating for the rest of the testing period suggesting that wearing
the bracelet did not affect the mood of the participants (see figure 2). More specifically
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there was no significant correlation between the PHQ-9 scores for question 3 and the
number of steps.

Scores

PHQ9 - QUESTION 3
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Days

FIGURE 2. MEAN SCORES ACROSS PARTICIPANTS FOR THE THIRD QUESTION OF THE
PHQ-9 BY DAY.
3.2.4. PHQ-9: QUESTION4:
Question 4 from the PHQ-9 covers fatigue and feelings of low energy. It asked
participants: “Over the last 24 hours, have you experienced feeling tired or having little
energy?” The relationship between days and PHQ-9-4 showed significant variance in
intercept across participants, Var(u0j) = .036, 2(1) = 63.36, p < .01. Days did not
significantly affect question 4 of the PHQ-9.
3.2.5. PHQ-9: QUESTION5:
The PHQ-9’s fifth question deals with appetite, asking the participants: “Over the last
24 hours, have you experienced poor appetite or over eating?” The relationship between
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days and PHQ-9-5 showed significant variance in intercept across participants, Var(u0j) =
.028, 2(1) = 52.5, p < .01. The variation in scores for question 5 of the PHQ-9 were
significantly affected by Days F(27,159.46) = 2.32, p = .001. Pairwise comparisons with
Bonferroni correction confirmed that question 5 for Day 27 differs from Day 5 (p = .004),
Day 13 (p = .016), Day 24 (p = .005), and Day 28 (p = .011). Table 1 summarizes the
mean and standard deviation of the scores for these questions. On Day 27, participants
averaged a score just under 2 (moderately experiencing poor appetite or over eating)
while scores for Days 5, 13, 24, and 28 are below .7 (between not at all experiencing poor
appetite or over eating and lightly experiencing poor appetite or over eating, Table 1).
Participants had more concern for food on Day 27 than any other days of interest.
TABLE 1. MEANS AND STANDARD DEVIATION FOR QUESTION 5 OF THE PHQ-9 FOR
DAYS 5, 13, 24, 27, AND 28
DAY

Mean (M)

SD

DAY 5

.64

.25

DAY 13

.69

.26

DAY 24

.82

.25

DAY 27

1.88

.26

DAY 28

.66

.28
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3.2.6. PHQ-9: QUESTION6:
Question 6 of the PHQ-9 focuses on feelings of failure and disappointment in oneself.
Participants were asked: “Over the last 24 hours, have you experienced feeling bad about
yourself – or that you are a failure or have let your family down?” The relationship
between days and PHQ-9-6 showed significant variance in intercept across participants,
Var(u0j) = .023, 2(1) = 55.07, p < .01. Question 6 of the PHQ-9 was almost significantly
affected by Days (p = .09). As shown on Figure 3, it seems that participants’ concerns
about disappointment and failures decrease over the first 13 days of the experiments but
start changing quickly on a daily basis until the end of the experiment. Again, no
correlation between the number of steps and the scores of question 6 were found for each
participant.

PHQ9 - QUESTION 6
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
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FIGURE 3. MEAN SCORES OF PHQ-9 QUESTION SIX BY DAY.
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3.2.7. PHQ-9: QUESTION7:
The seventh question of the PHQ-9 focuses on issues of concentration, asking the
participants: “Over the last 24 hours, have you experienced trouble concentrating on
things, such as reading the newspaper or watching television?” The relationship between
days and PHQ9-7 showed significant variance in intercept across participants, Var(u0j) =
.025, 2(1) = 31.75, p < .01. Days did not significantly affect question 7 of the PHQ-9.
3.2.8. PHQ-9: QUESTION8:
In question 8 of the PHQ-9, participants were asked: “Over the last 24 hours, have you
experienced moving or speaking so slowly that other people could have noticed? Or the
opposite – being so fidgety or restless that you have been moving around a lot more than
usual?” The relationship between days and PHQ-9-8 showed significant variance in
intercept across participants, Var(u0j) = .21, 2(1) = 42.17, p < .01.

Days did not

significantly affect question 8 of the PHQ-9.
3.2.9. PHQ-9: QUESTION9:
Question 9 of the PHQ-9 concerns thoughts of wanting to hurt oneself. The participant is
asked: “Over the last 24 hours, have you experienced thoughts that you would be better
off dead or hurting yourself in some way?” The relationship between days and PHQ-9-9
showed significant variance in intercept across participants, Var(u0j) = .09, 2(1) = 17.97,
p < .01. Days did not significantly affect question 9 of the PHQ-9

3.3.

RESULTS: STEPS AND PHQ-9 SUM SCORES

Correlating the number of daily steps to the PHQ-9 sum score by day per participant
produced a negative correlation for eight of eleven participants.
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Two participants

achieved statistical significance for the correlation, p < .05. Participant 2 achieved
significance at p = .01, however their correlation only included five data points and
should not be considered representative. Table 2 summarizes the correlation coefficient,
the coefficient of determination, and the significance value for each participant. Blue
cells denote a negative correlation.

Yellow highlights correlations which achieved

significance.

24

25

Figure 4. The number of steps per day (X-axis) correlated with the sum symptom
score for the daily PHQ-9 (Y-axis) by participant
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Table 2. Correlation strength between number of steps and PHQ-9 sum scores
P1

P2

P3

P4

P5

P6

P7

P8

P9

P10

P11

Pearson r

-.11

.95

.06

-.25

-.45

-.39

-.46

.03

-.22

-.05

-.30

R2

.01

.90

.00

.06

.20

.15

.21

.00

.05

.00

.09

Significance >.05 =.01 >.05 >.05 =.05 >.05 =.04 >.05 >.05 >.05 >.05

4. DISCUSSION
The results shows that relationship between days and all PHQ-9 questions displayed
significant variance in intercept across participants. This suggests depression symptoms
vary day to day among individuals wearing activity-tracking bracelets. However, there
were no significant variations in the question responses between the 28 days, except for
question 5 of the PHQ-9 dealing with poor appetite and overeating. The mean scores
increased significantly on day 27 and dropped significantly the following day. The
question however is confusing for daily tracking, as we cannot really know whether
scores increase for overeating or appetite loss, or a mix of both.
Days had no significant effect (p = .08) on Question 3 of the PHQ-9 (sleep
concerns), but again because the question deals with two opposing sleep issues, we are
unable to determine the measure’s relationship with walking over this period as
participants might be having trouble falling asleep one day and sleeping too much the
following day. Although it is suitable for a bi-weekly screening, monitoring sleep on a
daily basis requires a more precise question.
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Question 6 scores of the PHQ-9 (Feeling bad about oneself, or as though they
have failed their family) were not significant, and no correlation was found with the
number of steps.
There was no significant effect of Days on number of steps. We did find a
moderate negative correlation between the number of steps taken in a day for a
participant and their daily sum score on the PHQ-9. On days where participants reported
a higher number of steps their PHQ-9 sum score was generally lower than it was on days
where they took a lower number of steps.
The Jawbone Up™ bracelet was used because it was the cheapest on the market,
but had the drawback of including minimal features. It also required a USB connection
via a phone or a tablet and could not provide any feedback to the participants. The TudorLocke & Lutes (2009) study showed that individuals who wrote down their steps
increased their daily activity, suggesting that self-monitoring was a greater motivating
factor to increase activity than simply wearing an activity tracker. Although their study
did not address depression, it is possible that use of more sophisticated bracelets with
features that allow tracking and feedback would have been necessary to verify the initial
hypothesis that walking can help with depression over time.
An initial idea of the present was to develop a phone application intended to
motivate depressed persons and help them complete their daily activities.

The

application was to be a game where a digital avatar or “friend” would interact with the
depressed person through the user’s phone or tablet device, proposing engaging
challenges and offering encouragement based on the activity levels using a tracker.
During the literature review however, studies evaluating the specific act of walking and
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its effect on depression were scarce. Different articles explored various types of exercise
and their interaction with general mental and physical health.

A handful discussed

walking and mood changes, but did not focus specifically on depressed persons and the
correlation of their daily numbers of steps. Other research focused on guided walking at
various points in the week, but did not track participants’ walking outside of the sessions
with the researchers. The latter study’s neglect of that variable led to the current study.
This study recruited participants who exceeded a minimum threshold of
depression on a screener PHQ-9; accordingly, it was likely that there could be some
issues with data collection, such as missed nightly surveys, absent meet-ups to draw data
from the bracelets, or even willingness to participate beyond the prescreening. Weather
functioned as a limitation in this study as most of our data were collected in the winter
time where walking proves to be challenging or difficult. Additional limitations included
bracelets not being charged, resulting in participants wearing them for several days with
dead batteries and no data collected. Some participants attempted to submit surveys after
the fact for missed days, and some bracelets were damaged or lost all together. The low
interest in participation from male participants limited the possibility of comparing the
results based on gender. Having a small group of total participants was the greatest
limitation, and increasing the sample size would have provided more representative data
to describe the relationship between motivation and walking for depressed persons. This
study suggests that mild depression should be addressed on an individual basis and that
walking or wearing an activity monitor may benefit depression symptoms for some
people but not others.
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Adding reminders or rewards for reaching specific goals – features supported
already in new smartphones – might have improved compliance with the daily walking
regimen, and thus enhance any effect of activity monitoring on depression. When this
study began, more than two years ago, these features were not yet available. However,
since the purchase of the UP bracelet, the market exploded with new trackers that include
many features that could support walkers’ efforts to reach their goals.
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CONCLUSION
Minimal monitoring of daily activity for people suffering from mild depression is
not enough to reduce symptoms related to depression. Thus, wearing a basic activity
tracker is insufficient motivation for depressed persons to increase their daily walking,
but wearing trackers with more features might improve these outcomes. Such additional
features might include screens, activity reminders, or wireless connections to other
devices (like tablets or televisions) that might enhance the motivational component in
studies like this. The new generation of trackers could have sent reminders to the
participants’ other devices such as tablets or smartphones to help reduce missing
information.
The only significant result for Days on a question from the PHQ-9 involved
question 5, related to appetite loss or overeating. Two other questions, 3 and 6, which
dealt respectively with sleep and feeling bad about oneself yielded no significant results.
The drastic fluctuation between scores over days successive suggests additional factors
(e.g., procedural limitations, noted above) could have affected the results’ stability.
For the majority of participants, their numbers of steps in a day were inversely
related to their scores on the PHQ-9. This suggested that the number of steps a person
took per day may have had the effect of reducing depression symptom severity by the end
of the day, compared to days where the same participants took fewer steps. However, it
might also reflect simply that people walked more when less depressed than they did on
days when they are more depressed.
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APPENDIX A: MODIFIED PHQ-9 QUESTIONNAIRE
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APPENDIX B: TYPES OF DEPRESSION LISTED IN THE
DSM 5
In this section, the characteristics of each form of depression listed in the DSM 5’s
chapter “Depressive Disorders” are summarized.
Disruptive Mood Disregulation is distinguished by frequent (three times or more
per week) temper outbursts inconsistent with the individual’s level of development and
includes verbal rages and physical aggression against people or property. For example,
tantrums may be common for toddlers, but when constantly performed by a neurotypical
eight year old that child would possibly qualify for a diagnosis of Disruptive Mood
Disregulation. This diagnosis is generally reserved for children between the ages of 6
and 10 years and must be demonstrated consistently (without a gap of 3+ months) for at
least one year. The core feature is severe, persistent irritability.
Major Depressive Disorder requires the presence of five or more symptoms for
two consecutive weeks as well as either depressed mood or the loss of interest or
pleasure. The nine symptoms of which five must be present for diagnosis include:
- Depressed mood
Markedly diminished interest or pleasure in almost all activities on most days
- Significant weight loss or gain (5% of body weight in a month) when not dieting
or intentionally gaining weight
- Sleeping too much or too little (hypersomnia or insomnia, respectively)
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- Psychomotor agitation (restlessness) or retardation (sluggishness) observable by
others;
- Fatigue
- Feelings of worthlessness or excessive/inappropriate guilt
- Diminished ability to think or concentrate
- Recurrent thoughts of death including suicide attempts, plans for committing
suicide, and general suicide ideation without a plan.
The individual must have never had a manic episode. Documentation for this diagnosis
on medical forms includes the level of depression (mild, moderate, or severe) and can
denote when psychotic features are present.
Persistent Depressive Disorder consolidates chronic major depressive disorder
and dysthymic disorder as defined in the DSM-IV. It is a moderate but a persistent form
of depression, which is present for at least two years in adults or one year in children. It
must, along with depressed mood, include at least two or more of the following
symptoms in the same two years without more than a 2 month gap at any interval: poor
appetite or overeating; insomnia or hypersomnia; fatigue; low self-esteem; poor
concentration or indecision; feelings of hopelessness. The lower threshold for number of
symptoms and their persistence (two years rather than the minimum two weeks for Major
Depressive Disorder) is what distinguishes Dysthymia from Major Depressive Disorder.
Premenstrual dysphoric disorder is a new addition to the DSM 5 classification
after initially appearing in an appendix of DSM-IV only. As its name indicated, it is only
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specific to women. The authors of the DSM included it as a new diagnosis after 20 years
of research indicating that its onset after ovulation and persists within few days of
menstruation by distinctly affecting daily functioning.

The diagnosis requires a

combination of five symptoms or more from two lists of symptoms. Symptoms on the
first list include mood swings, irritability, depression/hopelessness, and anxiety. The
second list includes decreased interest in usual activities, subjective difficulty
concentrating, lethargy, changes in appetite including specific food cravings,
hypersomnia or insomnia, a sensation of being overwhelmed, and physical symptoms
such as weight gain, breast tenderness or swelling, joint or muscular pain, or a sensation
of “bloating.” Premenstrual dysphoric disorder differs from premenstrual syndrome as
this latter has no requirement for number of symptoms.
The Substance/Medication-induced depressive disorder is a prominent and
persistent disturbance of mood characterized by depressed mood or markedly diminished
interest or pleasure in most if not all activities during or following substance intoxication
or withdrawal, or exposure to a medication capable of producing the described
symptoms. This diagnosis is not appropriate if the depression precedes the exposure to
the substance/medication or if the individual is not significantly distressed or impaired in
their daily life.
An individual must have a history of another medical condition, which
physiologically leads to depression to qualify for Depressive Disorder due to Another
Medical Condition. Medical conditions related can include stroke, Cushing’s disease,
hypothyroidism, Huntington’s disease, Parkinson’s disease, and traumatic brain injury.
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This diagnosis is not to be used if the depression is better explained by another mental
disorder such as adjustment disorder with depressed mood.
Patients with symptoms characteristic of a depressive disorder but don’t qualify
for any defined disorder are diagnosed as Other Specified Depressive Disorder. This
diagnosis is used if a patient reports significant distress or impairment in daily
functioning and includes distinctions for 1) recurrent brief depression, 2) short-duration
depressive episode (4-13 days), and 3) depressive episode with insufficient symptoms.
Unspecified Depressive Disorder is quite similar to Other Specified Depressive
Disorder. This diagnosis is selected if the clinician is unable to specify which depressive
disorder their patient is expressing, and is intended for situations where there is not
sufficient time for a behavioral evaluation such as in an emergency room.
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